CLEMASTINE FUMARATE | 			
14976-57-9 | 
				
Tavist | 			
Agasten | 
				
Clemastine hydrogen fumarate | 			
Meclastine fumarate | 
				
Tavegil | 			
Clemastine (fumarate) | 
				
UNII-19259EGQ3D | 			
(R)-2-(2-((R)-1-(4-chlorophenyl)-1-phenylethoxy)ethyl)-1-methylpyrrolidine fumarate | 
				
CHEBI:3739 | 			
Mecloprodine | 
				
Aloginan | 			
Xolamin | 
				
19259EGQ3D | 			
(+)-(2R)-2-(2-(((R)-p-Chloro-alpha-methyl-alpha-phenylbenzyl)oxy)ethyl)-1-methylpyrrolidine fumarate (1:1) | 
				
14976-57-9 (FUMARATE) | 			
Alphamin | 
				
Anhistan | 			
Clemanil | 
				
Fuluminol | 			
Inbestan | 
				
Kinotomin | 			
Lacretin | 
				
Lecasol | 			
Maikohis | 
				
Marsthine | 			
Masletine | 
				
Piloral | 			
Reconin | 
				
Tavegyl | 			
Trabest | 
				
Mallermin-F | 			
Telgin-G | 
				
DSSTox_CID_27765 | 			
DSSTox_RID_82542 | 
				
DSSTox_GSID_47785 | 			
Tavist-1 | 
				
Meclastine hydrogen fumarate | 			
(2E)-but-2-enedioic acid; (2R)-2-{2-(1R)-1-(4-chlorophenyl)-1-phenylethoxyethyl}-1-methylpyrrolidine | 
				
(E)-but-2-enedioic acid;(2R)-2-2-(1R)-1-(4-chlorophenyl)-1-phenylethoxyethyl-1-methylpyrrolidine | 			
HSDB 6507 | 
				
Topcare dayhist allergy | 			
NCGC00016710-01 | 
				
Contac 12 Hour Allergy | 			
EINECS 239-055-2 | 
				
CAS-14976-57-9 | 			
(R)-2-2-(R)-1-(4-Chlorophenyl)-1-phenylethoxyethyl-1-methylpyrrolidine fumarate | 
				
Prestwick_680 | 			
Meclastine (fumarate) | 
				
Clemastinefumarate,(S) | 			
Clemastine fumarate USAN:USP:BAN:JAN | 
				
HS-592 (fumarate) | 			
(+)-2-(2-((p-Chloro-alpha-methyl-alpha-phenylbenzyl)oxy)ethyl)-1-methyl pyrrolidine fumarate | 
				
SCHEMBL33403 | 			
SCHEMBL41468 | 
				
SPECTRUM1500191 | 			
CHEMBL1200795 | 
				
DTXSID6047785 | 			
HMS500O07 | 
				
HY-B0298A | 			
HMS1568N14 | 
				
HMS1920O13 | 			
HMS2091E20 | 
				
HMS2095N14 | 			
HMS3267L12 | 
				
HMS3412B19 | 			
HMS3676B19 | 
				
HMS3712N14 | 			
HMS3884K12 | 
				
Pharmakon1600-01500191 | 			
BCP27945 | 
				
Tox21_110574 | 			
CCG-40028 | 
				
MFCD00137486 | 			
NSC756685 | 
				
s1847 | 			
AKOS015896237 | 
				
AKOS037643271 | 			
Tox21_110574_1 | 
				
AC-1338 | 			
NSC-756685 | 
				
NCGC00016710-05 | 			
NCGC00180903-01 | 
				
NCGC00180903-02 | 			
(R-(R*,R*))-2-(2-(1-(p-Chlorophenyl)-1-phenylethoxy)ethyl)-1-methylpyrrolidinium hydrogen fumarate | 
				
AS-12093 | 			
BC164321 | 
				
Pyrrolidine, 2-(2-((p-chloro-alpha-methyl-alpha-phenylbenzyl)oxy)ethyl)-1-methyl-, (+)-, fumarate (1:1) | 			
Pyrrolidine, 2-(2-(1-(4-chlorophenyl)-1-phenylethoxy)ethyl)-1-methyl-, (R-(R*,R*))-, (E)-2-butenedioate (1:1) | 
				
Clemastine fumarate salt, >=98% (HPLC) | 			
SW196835-3 | 
				
H10994 | 			
976C579 | 
				
SR-05000001590 | 			
SR-05000001590-1 | 
				
Q27106180 | 			
Clemastine fumarate, European Pharmacopoeia (EP) Reference Standard | 
				
Clemastine fumarate, United States Pharmacopeia (USP) Reference Standard | 			
(2R)-2-2-(1R)-1-(4-Chlorophenylethoxyethyl-1-methyl-2-pyrrolidine fumarate | 
				
Clemastine for system suitability, European Pharmacopoeia (EP) Reference Standard | 			
(2R)-2-2-(1R)-1-(4-chlorophenyl)-1-phenylethoxyethyl-1-methylpyrrolidin-1-ium;(E)-4-hydroxy-4-oxobut-2-enoate | 
				
(2R)-2-{2-(1R)-1-(4-chlorophenyl)-1-phenylethoxyethyl}-1-methylpyrrolidine (2E)-but-2-enedioate | 			
(2R)-2-{2-(1R)-1-(4-chlorophenyl)-1-phenylethoxyethyl}-1-methylpyrrolidinium (2E)-3-carboxyprop-2-enoate | 
				
Pyrrolidine,2-2-(1R)-1-(4-chlorophenyl)-1-phenylethoxyethyl-1-methyl-, (2R)-,(2E)-2-butenedioate (1:1) | 			
 |